Abstract
To determine how nuclease deactivated Cas9 (dCas9) or single-guide RNA (sgRNA) expression levels affect the knockdown efficiency of CRISPRi, we created K562 cell clones expressing KRAB-dCas9 protein either with the inducible Tet-on system or with the constitutive SFFV promotor. Single clones were selected by fluorescence-activated cell sorting (FACS) for further study. Six genes with various expression levels were targeted using lentiviral sgRNA from two libraries in four cell clones with various KRAB-dCas9 expression levels. The expression level of dCas9 protein/sgRNA levels and the knockdown efficiency were determined by flow cytometry. The cell clone with the highest KRAB-dCas9 expression level achieved effective CRISPRi knockdown. The data describing this clone were statistically different from that on other clones, indicating the strong KRAB-dCas9 expression might be a prerequisite for CRISPRi. By adopting different multiplicity of infection (MOI) in lentiviral transduction of this clone, we modified the expression level of sgRNA and found that the knockdown efficiency was neither affected by the target gene expression level nor correlated with KRAB-dCas9 levels, which remained relatively constant across all knockdown experiments (coefficient of variation = 2.2%). As an example, the following levels of the knockdowns: 74.72, 72.28 and 39.08% for mmadhc, rpia and znf148 genes, respectively, were achieved. These knockdown efficiencies correlated well with the respective sgRNA expression levels. Linear regression models built using this data indicate that the knockdown efficiency may be significantly affected by the levels of both KRAB-dCas9 and sgRNA. Notably, the sgRNA levels have greater impact, being a major factor affecting CRISPRi efficiency.
Similar content being viewed by others
REFERENCES
Evers B., Jastrzebski K., Heijmans J., Grernrum W., Beijersbergen R.L., Bernards R. 2016. CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes. Nat. Biotechnol. 34, 631–633.
Gilbert L.A., Horlbeck M.A., Adamson B., Villalta J.E., Chen Y.W., Whitehead E.H., Guimaraes C.P., Panning B., Ploegh H.L., Bassik M.C., Qi L.S., Kampmann M., Weissman J.S. 2014. Genome-scale CRISPR-mediated control of gene repression and activation. Cell. 159, 647‒661.
Yeo N.C., Chavez A., Lancebyrne A., Chan Y.C., Menn D.J., Milanova D., Kuo C.C., Guo X.G., Sharma S., Tung A., Cecchi R.J., Tuttle M., Pradhan S., Lim E.T., Davidsohn N., et al., 2018. An enhanced CRISPR repressor for targeted mammalian gene regulation. Nat. Methods. 15, 611‒616.
Peng H.Z., Ivanov A.V., Oh H.J., Lau Y.C., Rauscher F.J. 2009. Epigenetic gene silencing by the SRY protein is mediated by a KRAB-O protein that recruits the KAP1 co-repressor machinery. J. Biol. Chem. 284, 35670‒35680.
Hansen J.C., Ghosh R.P., Woodcock C.L. 2010. Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin. IUBMB Life. 62, 732‒738.
Ma H.H., Tu L.C., Naseri A., Huisman M., Zhang S.J., Grunwald D., Pederson T. 2016. CRISPR-Cas9 nuclear dynamics and target recognition in living cells. J. Cell Biol. 214, 529‒537.
Yang S.Z., Shi H.J., Chu X.R., Zhou X.L., Sun P.N. 2016. A rapid and efficient polyethyleneimine-based transfection method to prepare lentiviral or retroviral vectors: useful for making iPS cells and transduction of primary cells. Biotechnol. Lett. 38, 1631‒1641.
Kutner R.H., Zhang X.Y., Reiser J. 2009. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat. Protoc. 4, 495‒505.
Horlbeck M.A., Gilbert L.A., Villalta J.E., Adamson B.S., Pak R.A., Chen Y.W., Fields A.P., Park C.Y., Corn J.E., Kampmann M., Weissman J.S. 2016. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. eLlife. 5, e19760.
Sanson K.R., Hanna R.E., Hegde M., Donovan K.F., Strand C., Sullender M.E., Vaimberg E.W., Goodale A., Root D.E., Piccioni F., Doench J.G. 2018. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat. Commun. 9, 5416.
Stojic L., Lun A.T., Mangei J., Mascalchi P., Quarantotti V., Barr A.R., Bakal C., Marioni J.C., Gergely F., Odom D.T. 2018. Specificity of RNAi, LNA and CRISPRi as loss-of-function methods in transcriptional analysis. Nucleic Acids Res. 46, 5950‒5966.
Kustikova O.S., Wahlers A., Kuhlcke K., Stahle B., Zander A.R., Baum C., Fehse B. 2003. Dose finding with retroviral vectors: Correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. Blood. 102, 3934‒3937.
Martella A., Firth M., Taylor B.J., Goppert A., Cuomo E.M., Roth R.G., Dickson A.J., Fisher D.I. 2019. Systematic evaluation of CRISPRa and CRISPRi modalities enables development of a multiplexed, orthogonal gene activation and repression system. ACS Synth. Biol. 8, 1998‒2006.
Ahler E., Sullivan W.J., Cass A., Braas D., York A.G., Bensinger S.J., Graeber T.G., Christofk H.R. 2013. Doxycycline alters metabolism and proliferation of human cell lines. PLoS One. 8, e64561.
Yuen G., Khan F.J., Gao S.J., Stommel J.M., Batchelor E., Wu X.L., Luo J. 2017. CRISPR/Cas9-mediated gene knockout is insensitive to target copy number but is dependent on guide RNA potency and Cas9/sgRNA threshold expression level. Nucleic Acids Res. 45, 12039‒12053.
Mu W., Zhang Y.P., Xue X.T., Liu L., Wei X.F., Wang H.Y. 2019. 5′ Capped and 3′ polyA-tailed sgRNAs enhance the efficiency of CRISPR-Cas9 system. Protein Cell. 10, 223‒228.
Aubrey B.J., Kelly G.L., Kueh A.J., Brennan M.S., Oconnor L., Milla L., Wilcox S., Tai L., Strasser A., Herold M.J. 2015. An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo. Cell Rep. 10, 1422‒1432.
ACKNOWLEDGMENTS
We thank Professor Jonathan S. Weissman, David E. Root and John G. Doench for sharing their CRISPRi library on Addgene, and we acknowledge Dr. Luke A. Gilbert for offering advice on CRISPRi library.
Funding
This work was supported by the National Natural Science Foundation of China (81860652).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflict of interest.
This article does not contain any studies involving animals or human participants performed by any of the authors.
Additional information
ADDITIONAL INFORMATION
The text was submitted by the author(s) in English.
Supplementary Information
Rights and permissions
About this article
Cite this article
Wang, Y., Xie, Y., Dong, Z.C. et al. Levels of sgRNA as a Major Factor Affecting CRISPRi Knockdown Efficiency in K562 Cells. Mol Biol 55, 75–82 (2021). https://doi.org/10.1134/S0026893321010143
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893321010143